Carcinosarcoma of ovary - a rare case report and literature overview

Pushpagiri, Niroopama; Dinakaran, Shanthi; Chidambaram, Alagamai; Pari, Priya

doi:10.18203/2349-3933.ijam20161108

Cited by 1 publication

(1 citation statement)

References 7 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Therapeutic regimens can be simplified into platinum-based and those not containing platinum [1]. An overall response rate of 68% was reported in patients treated with platinum-based regimens compared with a response rate of 23% in patients treated with non-platinum regimens [19]. The usual treatment is platinum-based chemotherapy with taxane.…”

Section: Treatmentmentioning

confidence: 99%

Therapeutic Management of Rare Primary Ovarian Neoplasms: Carcinosarcoma, Leiomyosarcoma, Melanoma and Carcinoid

Kozłowski

Nowak

Kordek

et al. 2021

IJERPH

View full text Add to dashboard Cite

Carcinosarcoma, leiomyosarcoma, melanoma and carcinoid as primary tumors in the ovary are extremely rare. In this paper, the authors reviewed the literature from 2010 to 2021, based on specific criteria, to analyze the treatment of these rare ovarian neoplasms. We also aimed to verify whether modern therapies have been found in recent years. For this article, 80 papers were finally selected. The vast majority of the articles were clinical case reports. Despite single mentions of new potential pharmacological treatments, surgery (radical or fertility-sparing) is definitely the mainstay of treatment. There are currently no treatment guidelines for these tumors. A review of the literature has revealed the use of various adjuvant treatments. We, therefore, believe that a more detailed understanding of the biology of these tumors is necessary in order to find new target points for treatment. We would like to emphasize the importance of creating an international database of rare ovarian tumors which would make it possible to gather data from various oncological centers and enable further research into these neoplasms.

show abstract

Section: Treatmentmentioning

confidence: 99%